Search by Drug Name or NDC

    NDC 68084-0381-01 Benztropine Mesylate 0.5 mg/1 Details

    Benztropine Mesylate 0.5 mg/1

    Benztropine Mesylate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is BENZTROPINE MESYLATE.

    Product Information

    NDC 68084-0381
    Product ID 68084-381_f40e5386-976b-90cd-e053-2a95a90a9b4a
    Associated GPIs 73100010100305
    GCN Sequence Number 004589
    GCN Sequence Number Description benztropine mesylate TABLET 0.5 MG ORAL
    HIC3 H6B
    HIC3 Description ANTIPARKINSONISM DRUGS,ANTICHOLINERGIC
    GCN 17620
    HICL Sequence Number 001905
    HICL Sequence Number Description BENZTROPINE MESYLATE
    Brand/Generic Generic
    Proprietary Name Benztropine Mesylate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Benztropine Mesylate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/1
    Substance Name BENZTROPINE MESYLATE
    Labeler Name American Health Packaging
    Pharmaceutical Class Anticholinergic [EPC], Antihistamine [EPC], Cholinergic Antagonists [MoA], Histamine Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA040715
    Listing Certified Through 2024-12-31

    Package

    NDC 68084-0381-01 (68084038101)

    NDC Package Code 68084-381-01
    Billing NDC 68084038101
    Package 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-381-01) / 1 TABLET in 1 BLISTER PACK (68084-381-11)
    Marketing Start Date 2009-11-04
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.07254
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description BENZTROPINE MES 0.5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis